IL147731A0 - Peptide pharmaceutical formulations - Google Patents
Peptide pharmaceutical formulationsInfo
- Publication number
- IL147731A0 IL147731A0 IL14773101A IL14773101A IL147731A0 IL 147731 A0 IL147731 A0 IL 147731A0 IL 14773101 A IL14773101 A IL 14773101A IL 14773101 A IL14773101 A IL 14773101A IL 147731 A0 IL147731 A0 IL 147731A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical formulations
- peptide pharmaceutical
- peptide
- formulations
- pharmaceutical
- Prior art date
Links
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20526200P | 2000-05-19 | 2000-05-19 | |
PCT/US2001/015872 WO2001087322A2 (en) | 2000-05-17 | 2001-05-17 | Peptide pharmaceutical formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
IL147731A0 true IL147731A0 (en) | 2002-08-14 |
Family
ID=22761491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14773101A IL147731A0 (en) | 2000-05-19 | 2001-05-17 | Peptide pharmaceutical formulations |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1301200A2 (en) |
JP (1) | JP2004513069A (en) |
AU (1) | AU785444B2 (en) |
IL (1) | IL147731A0 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0306685A (en) | 2002-05-21 | 2005-04-26 | Daiichi Suntory Pharma Co Ltd | Pharmaceutical composition containing ghrelin |
WO2006022301A1 (en) * | 2004-08-24 | 2006-03-02 | Daiichi Asubio Pharma Co., Ltd. | Liquid preparation of physiologically active peptide |
KR100700869B1 (en) * | 2005-06-03 | 2007-03-29 | 재단법인 목암생명공학연구소 | The stabilized parathyroid hormone composition comprising parathyroid hormone buffer and stabilizing agent |
CN103405753B (en) * | 2013-08-13 | 2016-05-11 | 上海仁会生物制药股份有限公司 | Stable insulin secretion accelerating peptide liquid drugs injection pharmaceutical composition |
CN107952064B (en) * | 2016-10-14 | 2023-10-20 | 江苏豪森药业集团有限公司 | Pharmaceutical preparation containing polyethylene glycol lozenges and preparation method thereof |
EP3685849A4 (en) * | 2017-09-22 | 2021-12-22 | Asahi Kasei Pharma Corporation | Teriparatide-containing liquid pharmaceutical composition having excellent stability |
CA3167644A1 (en) | 2017-09-22 | 2019-03-28 | Asahi Kasei Pharma Corporation | Teriparatide-containing liquid pharmaceutical composition having excellent pharmacokinetics and/or safety |
JP2019060866A (en) * | 2017-09-22 | 2019-04-18 | 旭化成ファーマ株式会社 | Method for predicting biokinetics of liquid pharmaceutical composition |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0383931A (en) * | 1989-08-29 | 1991-04-09 | Sumitomo Pharmaceut Co Ltd | Low-irritating grf pernasal administration pharmaceutical |
UA65549C2 (en) * | 1996-11-05 | 2004-04-15 | Елі Ліллі Енд Компані | Use of glucagon-like peptides such as glp-1, glp-1 analog, or glp-1 derivative in methods and compositions for reducing body weight |
ZA9811127B (en) * | 1997-12-09 | 2000-07-11 | Lilly Co Eli | Stabilized teriparatide solutions. |
JP4072319B2 (en) * | 1998-03-13 | 2008-04-09 | ノヴォ ノルディスク アクティーゼルスカブ | Stabilized water-soluble peptide solution |
EP1064934A1 (en) * | 1999-06-30 | 2001-01-03 | Applied Research Systems ARS Holding N.V. | GRF-containing lyophilized pharmaceutical composition |
-
2001
- 2001-05-17 IL IL14773101A patent/IL147731A0/en unknown
- 2001-05-17 AU AU74839/01A patent/AU785444B2/en not_active Ceased
- 2001-05-17 JP JP2001583789A patent/JP2004513069A/en active Pending
- 2001-05-17 EP EP01941488A patent/EP1301200A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1301200A2 (en) | 2003-04-16 |
AU7483901A (en) | 2001-11-26 |
AU785444B2 (en) | 2007-06-14 |
JP2004513069A (en) | 2004-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0319041D0 (en) | Pharmaceutical Formulations | |
GB0001621D0 (en) | Pharmaceutical compositions | |
AU6219601A (en) | Pharmaceutical compositions | |
AU8576801A (en) | Pharmaceutical compositions | |
GB0120701D0 (en) | Pharmaceutical formulations | |
GB0103638D0 (en) | Pharmaceutical formulations | |
GB0121715D0 (en) | Pharmaceutical formulations | |
AU1390002A (en) | Pharmaceutical compositions | |
GB0008485D0 (en) | Pharmaceutical compositions | |
GB2380129B (en) | Pharmaceutical formulations | |
GB0105560D0 (en) | Pharmaceutical formulations | |
HK1045102A1 (en) | Pharmaceutical formulations | |
IL147731A0 (en) | Peptide pharmaceutical formulations | |
AU2001296389A1 (en) | Stable peptide formulations | |
GB0014851D0 (en) | Novel pharmaceutical formulation | |
GB9906126D0 (en) | Pharmaceutical formulations | |
GB9930578D0 (en) | Pharmaceutical formulations | |
GB0014947D0 (en) | Novel pharmaceutical formulation | |
GB0014892D0 (en) | Novel pharmaceutical formulation | |
GB0014883D0 (en) | Novel pharmaceutical formulation | |
IL135442A0 (en) | Peptides and pharmaceutical compositions comprising them | |
GB0124455D0 (en) | Pharmaceutical formulations | |
GB0021487D0 (en) | Pharmaceutical | |
EP1414417A4 (en) | Pharmaceutical formulation | |
IL136274A0 (en) | Pharmaceutical compositions comprising vip-related peptides |